FDA NDC Directory · JSON-LD · Markdown

MEPRON

NDC 0173-0665 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic nameatovaquone
Labeler / ManufacturerGlaxoSmithKline LLC
Marketing categoryNew Drug Application (innovator) · App NDA020500
Dosage form / routeSUSPENSION · ORAL
Active ingredientsATOVAQUONE (750 mg/5mL)
Marketing started19950228
Package count1

External sources

Source: openFDA. Public-domain (CC0).